Captrust Financial Advisors Boosts Amgen Inc. Stake by 5.9%

Institutional investor now owns $137 million in Amgen shares

Mar. 18, 2026 at 8:36am

Got story updates? Submit your updates here. ›

Captrust Financial Advisors, an institutional investor, increased its stake in Amgen Inc. (NASDAQ:AMGN) by 5.9% in the third quarter, according to a recent SEC filing. The firm now owns 485,703 shares of the medical research company's stock, valued at $137,065,000.

Why it matters

Amgen is a major player in the biotechnology industry, and changes in institutional ownership of its stock can provide insights into investor sentiment and market trends surrounding the company.

The details

Captrust Financial Advisors, a North Carolina-based investment advisory firm, boosted its position in Amgen by adding 27,233 shares in the third quarter. This increased the firm's total holdings in Amgen to approximately 0.09% of the company's outstanding shares. The move comes as Amgen has seen increased analyst coverage and positive sentiment around its pipeline and financial performance.

  • Captrust Financial Advisors increased its Amgen stake in the third quarter of 2026.

The players

Captrust Financial Advisors

A North Carolina-based investment advisory firm that manages over $60 billion in client assets.

Amgen Inc.

A global biotechnology company that focuses on developing and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

Captrust's increased stake in Amgen suggests the firm sees continued growth potential in the biotech company, which could signal broader investor optimism around Amgen's product pipeline and financial outlook.